Sangel Venture is one of the earliest globally established professional biomedical venture investment institutions established in China. We focus on life science and technology, and have leading professional advantages and rich project resources in the biomedical investment industry. Based on the most promising industries, Sangel Venture taps innovative growth enterprises with great capital value and commercial potential, and cultivates a number of benchmarks for subdivided industries.

Sangel Capital has offices in Shenzhen, Beijing, Suzhou, and Chicago. We bring together a group of investment and advisory teams composed of industry experts, scientists, and investors in the field of life technology to manage and operate a series of RMB and USD funds.